BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2611666)

  • 1. Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain.
    Meyerhoff JL; Robinson MB; Bixler MA; Richards SS; Coyle JT
    Brain Res; 1989 Dec; 505(1):130-4. PubMed ID: 2611666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate.
    Meyerhoff JL; Carter RE; Yourick DL; Slusher BS; Coyle JT
    Brain Res; 1992 Oct; 593(1):140-3. PubMed ID: 1360862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity.
    Blakely RD; Robinson MB; Thompson RC; Coyle JT
    J Neurochem; 1988 Apr; 50(4):1200-9. PubMed ID: 3346674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate.
    Serval V; Barbeito L; Pittaluga A; Cheramy A; Lavielle S; Glowinski J
    J Neurochem; 1990 Jul; 55(1):39-46. PubMed ID: 2355230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase).
    Slusher BS; Tsai G; Yoo G; Coyle JT
    J Comp Neurol; 1992 Jan; 315(2):217-29. PubMed ID: 1545010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
    Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
    Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo.
    Stauch BL; Robinson MB; Forloni G; Tsai G; Coyle JT
    Neurosci Lett; 1989 May; 100(1-3):295-300. PubMed ID: 2668802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of glutamate carboxypeptidase II (NAALADase) enzyme activity by the hydrolysis of [³H]-N-acetylaspartylglutamate (NAAG).
    Tiffany CW; Slusher BS
    Curr Protoc Pharmacol; 2002 Feb; Chapter 3():Unit3.10. PubMed ID: 21959764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase.
    Jackson PF; Cole DC; Slusher BS; Stetz SL; Ross LE; Donzanti BA; Trainor DA
    J Med Chem; 1996 Jan; 39(2):619-22. PubMed ID: 8558536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.
    Passani LA; Vonsattel JP; Carter RE; Coyle JT
    Mol Chem Neuropathol; 1997 Jun; 31(2):97-118. PubMed ID: 9376025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibition of N-acetyl-L-aspartyl-L-glutamate catabolism by N-acylated L-glutamate analogs.
    Serval V; Galli T; Cheramy A; Glowinski J; Lavielle S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1093-100. PubMed ID: 1545381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kindling increases brain levels of NAAG and seizures reduce activity of a NAAG-hydrolyzing enzyme, NAALADase.
    Meyerhoff JL; Robinson MB; Koller KJ; Bixler MA; Coyle JT
    Epilepsy Res Suppl; 1992; 8():297-305. PubMed ID: 1358101
    [No Abstract]   [Full Text] [Related]  

  • 13. N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitro.
    Koenig ML; Rothbard PM; DeCoster MA; Meyerhoff JL
    Neuroreport; 1994 May; 5(9):1063-8. PubMed ID: 8080959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
    Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain levels of N-acetyl-aspartyl-glutamate: the effect of kindled seizures.
    Meyerhoff JL; Koller KJ; Walczak DD; Coyle JT
    Brain Res; 1985 Nov; 346(2):392-6. PubMed ID: 4052789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
    Carter RE; Feldman AR; Coyle JT
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):749-53. PubMed ID: 8570628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system.
    Fuhrman S; Palkovits M; Cassidy M; Neale JH
    J Neurochem; 1994 Jan; 62(1):275-81. PubMed ID: 8263527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate binding sites.
    Blakely RD; Robinson MB; Guarda AS; Coyle JT
    Eur J Pharmacol; 1988 Jul; 151(3):419-26. PubMed ID: 2850921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.
    Robinson MB; Blakely RD; Couto R; Coyle JT
    J Biol Chem; 1987 Oct; 262(30):14498-506. PubMed ID: 3667587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method.
    Koller KJ; Zaczek R; Coyle JT
    J Neurochem; 1984 Oct; 43(4):1136-42. PubMed ID: 6470709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.